Read the latest from Baszucki Group and its partners.
April 1, 2024 — Peer-reviewed clinical pilot trial from Stanford University reports dramatic improvements in psychiatric and metabolic outcomes in bipolar disorder and schizophrenia patients.
March 29, 2024 — Baszucki Group is proud to support bipolar disorder research at the University of Edinburgh Department of Psychiatry. Learn more from it’s department chair, Professor Daniel Smith, and Dr. Iain Campbell, a Baszucki Brain Research Fund fellow.
March 21, 2024 — Baszucki Group announced in funding $6 million awarded to a research team led by University of Pittsburgh Psychiatry professor and researcher, Mary L. Phillips, MD, MD (Cantab). The funding will support the creation of a multidisciplinary research team focusing on the intersection of neuroscience, psychiatry, and metabolism.
March 5, 2024 — Baszucki Group announced that Columbia University’s Martin Picard, PhD, is the first to receive the new Baszucki Prize in Science. Dr. Picard, Associate Professor of Behavioral Medicine in Psychiatry and Neurology, received the $1.5 million prize for his groundbreaking work connecting brain energetics and mitochondria to the human experience.